The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
about
Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progressLongitudinal anti-müllerian hormone in women with polycystic ovary syndrome: an acupuncture randomized clinical trial.Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease?Increased androgen, anti-Müllerian hormone, and sporadic anovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype?Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients.Genome-wide methylated DNA immunoprecipitation analysis of patients with polycystic ovary syndrome.Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females.Lack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome.Evaluation of relationship between serum levels of anti-müllerian hormone, androgen, and insulin resistant with retrieval oocytes in overweight patients with polycystic ovary syndrome.The role of anti-Mullerian hormone and inhibin B in the assessment of metformin therapy in women with polycystic ovarian syndromeCorrelation of serum Anti-Müllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients.Assessment of Anti-Müllerian Hormone Level in Management of Adolescents with Polycystic Ovary Syndrome.Involvement of androgens in ovarian health and disease.Association between serum gonadotropin level and insulin resistance-related parameters in Korean women with polycystic ovary syndromeRace/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling womenGenetics of androgen metabolism in women with infertility and hypoandrogenism.Is foetal hyperexposure to androgens a cause of PCOS?Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine.The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.Basal serum testosterone levels correlate with ovarian reserve and ovarian response in cycling women undergoing in vitro fertilization.Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization.A teleost androgen promotes development of primary ovarian follicles in coho salmon and rapidly alters the ovarian transcriptome.Is polycystic ovary syndrome an exception for reproductive aging?Anti-Müllerian hormone levels in women with polycystic ovarian syndrome compared with normal women of reproductive age in China.Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS.Effect of sleeve gastrectomy bariatric surgery-induced weight loss on serum AMH levels in reproductive aged women.Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?Dipeptidyl peptidase 4 serum activity and concentration are increased in women with polycystic ovary syndrome.1-h Postprandial glucose level is related to the serum anti-Müllerian hormone level in women with polycystic ovary syndrome.Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome.Relationship between serum anti-Mullerian hormone with vitamin D and metabolic syndrome risk factors in late reproductive-age women.Differential response of AMH to GnRH agonist among individuals: the effect on ovarian stimulation outcomes.The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome.Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile.Prevalence of diminished ovarian reserve in Chinese women with polycystic ovary syndrome and sensitive diagnostic parameters.Circulating leptin concentrations do not distinguish menstrual status in exercising women.Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome.
P2860
Q26773554-F91854EE-1EBF-4312-9FCD-B5B1D1BDC98EQ28388248-87856B5E-9E7F-4FB7-9B4A-8D7FFE1A3385Q28391817-ED21AB67-6D8F-4592-A2BB-C63C869C2212Q33682407-ABB69D43-F4BD-47C4-9E3D-832B8B683CA8Q33907212-86CFB789-F98F-4BB5-92F0-D29996394DD0Q34181497-A4BC3F93-E1B3-495B-8541-F6478571DC97Q34226461-36E8CBC6-484F-435D-9F4C-DE772C9AA223Q34738226-CE76DD9A-AA1F-4337-A7E8-B503002E210AQ34769332-A8A796C2-CF3E-4AF2-948B-E310DE1D5050Q34810982-56E7F866-7EBE-4F5A-A6F9-A203C9CEDD44Q35277817-16D39AD5-E388-4D7C-9D5F-B7A0549795AAQ35621711-9677CD7C-4F62-48B2-BB41-784A42EBCABDQ35946575-26EE8571-A362-4668-8CD8-7761EFD694B7Q36722033-F6BA1C37-20B0-4252-8437-9CE6A8CC0C9DQ37348830-C55653C6-4678-405D-ACC6-C82364EA8D22Q37430285-39405067-FA47-4263-858E-552E415CE434Q37685259-BE54522E-1806-40B0-9761-C519607D8315Q38460006-E9FAEB0A-EDF7-4F80-8357-96CA5F2292B1Q38771084-7B3CE167-9DAD-4D5A-A836-566696ACF98AQ39393122-43736D72-71DA-4F54-92FE-242185BA165DQ40863688-E58087A4-3C20-44E1-B1BA-D6DAD095DDE3Q41459339-1301AC0D-3B09-41AB-8A49-F26D456898BFQ42495824-EF970B17-FCC5-423A-90AF-FA807507562DQ42778208-86E51780-A20F-4360-9C42-AC620A910579Q43077067-B10DF328-EBF3-4701-BBB0-1E2886048C17Q43779945-3BC54E9E-AA6F-44AB-AC0D-CEC7EE2077BCQ43839198-4B05A134-870E-4229-B014-E8C07C7F76E6Q47310522-5DBD4CF6-9845-40A2-B3BA-F451ECAD5B41Q47629555-959CDBA2-7366-4202-950B-B6B787691C02Q47670005-E80BFD80-CC73-47E0-BC5A-7B29152C8509Q48025348-8814754D-C5ED-4399-9422-F2F7451A3B7EQ48253033-C315140D-918D-4E56-972A-298721F79C45Q48361579-886935CA-DB62-4AF5-B4BB-4433C5AA45FDQ48505409-43168DE3-D149-47C4-A7A6-C70F7010F0BBQ48661094-4B3B974F-81F1-4027-8D25-9964A825D06BQ50665296-376B994C-2A1A-4EDC-9615-C294D5A9DA30Q51444233-45A9112E-2336-403C-8DD3-5A64CDC0AFE9Q51828295-358073D9-F1F9-4679-9F85-A471DC549383Q53443109-CB297276-DAB9-4A1A-8083-13F55CCA7548Q53782079-824B6ADC-8980-433F-A762-129900A3AF9D
P2860
The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
The relationships between AMH, ...... out polycystic ovary syndrome.
@en
The relationships between AMH, ...... out polycystic ovary syndrome.
@nl
type
label
The relationships between AMH, ...... out polycystic ovary syndrome.
@en
The relationships between AMH, ...... out polycystic ovary syndrome.
@nl
prefLabel
The relationships between AMH, ...... out polycystic ovary syndrome.
@en
The relationships between AMH, ...... out polycystic ovary syndrome.
@nl
P2093
P2860
P356
P1433
P1476
The relationships between AMH, ...... out polycystic ovary syndrome.
@en
P2093
Luciano G Nardo
Phil Pemberton
P2860
P304
P356
10.1093/HUMREP/DEP225
P407
P577
2009-07-18T00:00:00Z